FDA approves improved Oracle Micro catheter

July 19, 1995

Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus,

Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus, whichcombines on a single catheter a solid-state imaging transducerand a percutaneous transluminal coronary angioplasty (PTCA) balloon.Endosonics said Oracle Micro Plus confers significant advantagesover its previous version of the product, which the FDA approvedlast year (SCAN 10/26/94). Oracle Micro Plus is especially wellsuited for coronary stenting procedures, the company said.